Christopher Clement
Foot & Ankle Surgery · Hazard, KYNPI 1205212537
Payments from drug & device makers
What this record shows
20 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 28.7% of the total. Reporting peaked in 2019 at $4,556 and has fallen 63.2% since, to $1,676 in 2025.
Across 100 payments — averaging $82.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$2K
- Stryker$2K
- Orthofix Medical, Inc.$1K
- Organogenesis Inc.$778
- Paragon 28, Inc.$584
- Crossroads Extremity Systems, LLC$581
- plus $913 from 14 others
What the payments were for
- Travel & lodging$4,38853%
- Food & beverage$3,82547%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 10 | $2,354 |
| Stryker(2 entities) | 28 | $1,563 |
| Orthofix Medical, Inc. | 14 | $1,439 |
| Organogenesis Inc. | 21 | $778 |
| Paragon 28, Inc. | 3 | $584 |
| Crossroads Extremity Systems, LLC | 4 | $581 |
| Kerecis Limited | 3 | $336 |
| Smith+Nephew | 2 | $145 |
| Paratek Pharmaceuticals, Inc. | 2 | $143 |
| Integra Lifesciences Corporation | 1 | $53 |
| Averitas Pharma Inc. | 2 | $49 |
| AbbVie | 2 | $39 |
| Fusion Orthopedics USA, LLC | 1 | $27 |
| Reapplix Inc. | 1 | $22 |
| Innovation Technologies Inc | 1 | $21 |
| Mimedx Group, Inc. | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Polynovo North America LLC | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LAPIPLASTY SYSTEM 1$1,439
- TL-HEX$1,136
- TrueLok Ring Fixation System$1,136
- Lapiplasty System$813
- ANCHORAGE$349
- Kerecis Omega3 Wound$299
- HOFFMANN$149
- COLLAGENASE SANTYL$125
- NUZYRA$125
- STAR$109
- VARIAX$109
- T2$109
- PuraPly$107
How this compares
$8,213 in reported general payments places this provider in the 75th percentile of 141 foot & ankle surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 67 | $2,455 |
| Cephalexin | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Hazard
- William Adams IiPaducah$485K
- Sofie PinneyCynthiana$130K
- Carl KihmLouisville$89K
- Bradford FineLexington$82K
- Nicholas LacoLouisville$60K
- Jay LechnerLouisville$29K
- Russell BakerCarrollton$27K
- William McGloneLouisville$26K
- Timothy FordLouisville$26K
- Garrett WiremanLouisville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.